Literature DB >> 16082302

Predictors of remission from body dysmorphic disorder: a prospective study.

Katharine A Phillips1, Maria E Pagano, William Menard, Christina Fay, Robert L Stout.   

Abstract

In the first naturalistic, prospective study of the course of body dysmorphic disorder (BDD), we examined predictors of remission in 161 subjects over 1 year of follow-up. Data were obtained on clinical characteristics at the intake interview and weekly BDD symptom severity over 1 year using the Longitudinal Interval Follow-Up Evaluation. More severe BDD at intake, longer BDD duration, and the presence of a comorbid personality disorder predicted a lower likelihood of partial or full remission from BDD. BDD remission was not predicted by gender; race/ethnicity; socioeconomic status; being an adult versus an adolescent; age of BDD onset; delusionality of BDD symptoms; or the presence at intake of major depression, a substance use disorder, social phobia, obsessive compulsive disorder, or an eating disorder. Receipt of mental health treatment or nonmental health treatment (e.g., surgery, dermatologic treatment) during the follow-up year also did not predict remission from BDD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082302      PMCID: PMC1397711          DOI: 10.1097/01.nmd.0000172681.51661.54

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  24 in total

1.  A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale.

Authors:  K A Phillips; E Hollander; S A Rasmussen; B R Aronowitz; C DeCaria; W K Goodman
Journal:  Psychopharmacol Bull       Date:  1997

2.  Nonpsychiatric medical treatment of body dysmorphic disorder.

Authors:  Canice E Crerand; Katharine A Phillips; William Menard; Christina Fay
Journal:  Psychosomatics       Date:  2005 Nov-Dec       Impact factor: 2.386

3.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

Authors:  R L Spitzer; J B Williams; M Gibbon; M B First
Journal:  Arch Gen Psychiatry       Date:  1992-08

4.  Body dysmorphic disorder. A survey of fifty cases.

Authors:  D Veale; A Boocock; K Gournay; W Dryden; F Shah; R Willson; J Walburn
Journal:  Br J Psychiatry       Date:  1996-08       Impact factor: 9.319

5.  A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases.

Authors:  K A Phillips; S L McElroy; P E Keck; J I Hudson; H G Pope
Journal:  Psychopharmacol Bull       Date:  1994

Review 6.  Effect of personality disorders on the treatment outcome of axis I conditions: an update.

Authors:  J H Reich; R G Vasile
Journal:  J Nerv Ment Dis       Date:  1993-08       Impact factor: 2.254

7.  Reliability and validity of the longitudinal interval follow-up evaluation for assessing outcome of anxiety disorders.

Authors:  M G Warshaw; M B Keller; R L Stout
Journal:  J Psychiatr Res       Date:  1994 Nov-Dec       Impact factor: 4.791

8.  Bipolar I: a five-year prospective follow-up.

Authors:  M B Keller; P W Lavori; W Coryell; J Endicott; T I Mueller
Journal:  J Nerv Ment Dis       Date:  1993-04       Impact factor: 2.254

9.  Importance of psychotic features to long-term course in major depressive disorder.

Authors:  W Coryell; A Leon; G Winokur; J Endicott; M Keller; H Akiskal; D Solomon
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

10.  Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.

Authors:  M B Keller; P W Lavori; T I Mueller; J Endicott; W Coryell; R M Hirschfeld; T Shea
Journal:  Arch Gen Psychiatry       Date:  1992-10
View more
  8 in total

1.  High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.

Authors:  W Louis Cleveland; Robert L DeLaPaz; Rashid A Fawwaz; Roger S Challop
Journal:  Neural Plast       Date:  2010-02-18       Impact factor: 3.599

2.  The clinical course of body dysmorphic disorder in the Harvard/Brown Anxiety Research Project (HARP).

Authors:  Andri S Bjornsson; Ingrid Dyck; Ethan Moitra; Robert L Stout; Risa B Weisberg; Martin B Keller; Katharine A Phillips
Journal:  J Nerv Ment Dis       Date:  2011-01       Impact factor: 2.254

3.  The Presentation of Body Dysmorphic Disorder in Medical Settings.

Authors:  Katharine A Phillips
Journal:  Prim psychiatry       Date:  2006-07

4.  Surgical and minimally invasive cosmetic procedures among persons with body dysmorphic disorder.

Authors:  Canice E Crerand; William Menard; Katharine A Phillips
Journal:  Ann Plast Surg       Date:  2010-07       Impact factor: 1.539

5.  Functional impairment in body dysmorphic disorder: a prospective, follow-up study.

Authors:  Katharine A Phillips; Gene Quinn; Robert L Stout
Journal:  J Psychiatr Res       Date:  2008-04-02       Impact factor: 4.791

Review 6.  Body dysmorphic disorder.

Authors:  Andri S Bjornsson; Elizabeth R Didie; Katharine A Phillips
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

7.  Affective touch topography and body image.

Authors:  Valentina Cazzato; Sofia Sacchetti; Shelby Shin; Adarsh Makdani; Paula D Trotter; Francis McGlone
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

Review 8.  Comorbidity between obsessive-compulsive disorder and body dysmorphic disorder: prevalence, explanatory theories, and clinical characterization.

Authors:  Álvaro Frías; Carol Palma; Núria Farriols; Laura González
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-26       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.